Effective Treatment for Chronic Hepatitis C
Velpanat is a highly effective, fixed-dose combination medication used for the treatment of chronic Hepatitis C virus (HCV) infection. It contains two powerful direct-acting antivirals (DAAs): Sofosbuvir (400 mg) and Velpatasvir (100 mg).
As a pan-genotypic treatment, Velpanat is designed to work against all six major genotypes (Genotypes 1–6) of the Hepatitis C virus. This makes it a versatile and reliable option for patients regardless of their specific virus strain.
How Velpanat Works
The two active ingredients in Velpanat work together to stop the virus from multiplying:
- Sofosbuvir inhibits the NS5B RNA-dependent RNA polymerase, an enzyme the virus needs to replicate.
- Velpatasvir targets the NS5A protein, which is essential for the assembly and release of new viral particles.
Dosage and Treatment Duration
For most patients, the standard regimen involves taking one tablet daily at the same time each day. A full treatment course typically lasts 12 weeks, which requires three packs of 28 tablets. It is important to complete the entire course as prescribed by your healthcare provider to ensure the virus is fully cleared from your system.
Professional Guidance
If you have questions about treating Hepatitis C or managing side effects, you can speak with a GoMed pharmacist for professional advice and support. Always ensure you have a valid prescription before starting this medication.
Storage Information
Store Velpanat in a cool, dry place below 30°C. Keep the bottle tightly closed and out of the reach of children.